229 results
8-K
EX-10.1
ATRX
Adhera Therapeutics, Inc.
29 Jun 23
Entry into a Material Definitive Agreement
4:54pm
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits
8-K
EX-10.1
ATRX
Adhera Therapeutics, Inc.
5 May 23
Entry into a Material Definitive Agreement
4:02pm
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits
8-K
EX-10.1
ATRX
Adhera Therapeutics, Inc.
4 May 23
Entry into a Material Definitive Agreement
4:05pm
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits
8-K
EX-10.1
wx7v57pe
12 Nov 21
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-10.1
k440ytj6 tun2
13 Oct 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-4.2
toa5 rqeb2rlurm
18 Aug 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.1
pcvpqk artsuryk34oax
4 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
dc0cs hh4e4s
23 Apr 21
Adhera Therapeutics Appoints Trond K. Waerness to Board of Directors
9:15am
8-K
EX-4.1
v5448qf6t1shkz rx
9 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
EX-10.1
t4pst1u2l
13 Jul 20
Entry into a Material Definitive Agreement
7:58am
8-K
EX-10.1
l7wm sm491jp9b54
11 Feb 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
lvjfdj5f2smcdimz
4 Nov 19
Entry into a Material Definitive Agreement
4:15pm
SC TO-I
ascw91f8 9v4th7jl6pz
20 Aug 19
Issuer tender offer statement
5:01pm
SC TO-I
EX-99
mtqgj5knh0ju
20 Aug 19
Issuer tender offer statement
5:01pm